Acurx Pharmaceuticals, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:ACXP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -2.25 M-2.05 M-1.67 M-1.88 M-1.18 M-1.41 M -6.14 M Cash from investing activities —————— — Cash from financing activities 194.55 K2.99 M3.09 M1.72 M2.83 M3.11 M 10.75 M Free cash flow -2.25 M-2.05 M-1.67 M-1.88 M-1.18 M-1.41 M -6.14 M

News

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's Why

Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?

Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript

Earnings call transcript: Acurx Pharmaceuticals Q4 2025 reveals cash boost and R&D progress

Acurx Pharmaceuticals stock gains over 3% on new rCDI trial launch

What's Going On With Acurx Pharmaceuticals Stock Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Why Is Acurx Pharmaceuticals Stock Falling Thursday? - Acurx Pharmaceuticals (NASDAQ:ACXP)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.61%

Why Is Acurx Pharmaceuticals Stock Up Over 105% Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?

Acurx Pharmaceuticals, Inc. (ACXP) Q3 2025 Earnings Call Transcript

Acurx’s ibezapolstat shows microbiome-sparing properties in trials